Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Snehal K ShuklaNishant S KulkarniPamela FarralesDipti D KanabarVineela ParvathaneniNitesh K KundaAaron MuthVivek GuptaPublished in: Pharmaceutical research (2020)
The localized delivery of SF-loaded nanoparticles resulted in improved anti-tumor activity as compared to SF alone. Therefore, this strategy displays great potential as a novel treatment approach against certain lung cancers.